Evaluation of pragmatic oxygenation measurement as a proxy for Covid-19 severity

ISARIC4C Investigators, Christopher Green

Research output: Contribution to journalArticlepeer-review

15 Downloads (Pure)
Original languageEnglish
Article number7374
JournalNature Communications
Volume14
DOIs
Publication statusPublished - 15 Nov 2023

Bibliographical note

This work uses data provided by patients and collected by the NHS as part of their care and support. We are extremely grateful for the front-line NHS clinical and research staff and volunteer medical students who collected this data in challenging circumstances, and the generosity of the participants and their families for their individual contributions in these difficult times. We also acknowledge the support of Jeremy J Farrar (Wellcome Trust) and Nahoko Shindo (WHO). For the purpose of open access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission. JKB gratefully acknowledges funding support from a Wellcome Trust Senior Research Fellowship (223164/Z/21/Z), UKRI grants MC_PC_20004, MC_PC_19025, MC_PC_1905, MRNO2995X/1, and MC_PC_20029, Sepsis Research (Fiona Elizabeth Agnew Trust), a BBSRC Institute Strategic Programme Grant to the Roslin Institute (BB/P013732/1, BB/P013759/1), and the UK Intensive Care Society. ISARIC4C work was supported by the National Institute for Health Research (NIHR), the Medical Research Council [MC_PC_19059] and by the NIHR Health Protection Research Unit (HPRU) in Emerging and Zoonotic Infections at University of Liverpool in partnership with Public Health England (PHE), in collaboration with Liverpool School of Tropical Medicine and the University of Oxford [200907], NIHR HPRU in Respiratory Infections at Imperial College London with PHE [200927], Wellcome Trust and Department for International Development [215091/Z/18/Z], and the Bill and Melinda Gates Foundation [OPP1209135], and Liverpool Experimental Cancer Medicine Centre (C18616/A25153), NIHR Biomedical Research Centre at Imperial College London [IS-BRC-1215-20013], EU Platform for European Preparedness Against (Re-) emerging Epidemics (PREPARE) [FP7 project 602525] and NIHR Clinical Research Network for providing infrastructure support for this research.

Cite this